Literature DB >> 25834485

Mean platelet volume in brucellosis: correlation between brucella standard serum agglutination test results, platelet count, and C-reactive protein.

Dogan Halef Okan1, Zararsiz Gökmen2, Bayik Seyit3, Koca Yuksel1, Zungun Cevdet1, Akbulut Deniz1.   

Abstract

BACKGROUND: Brucellosis, a zoonotic infection, was most widely diagnosed by the Brucella standard serum agglutination test (SAT). No previous publication has demonstrated a correlation between the degree of Brucella SAT agglutination positivity and the severity of brucellosis infection.
OBJECTIVE: To contribute to the clarification of the relationship between patelets and brucellosis. It is also aimed at evaluating the usefulness of the SAT titer as a measure of brucellosis severity.
MATERIAL AND METHODS: We compared the control (n=60) and patients (n=96) groups in terms of mean platelet volume (MPV), C-reactive protein (CRP) and platelet values. Patients were grouped according to their degree of agglutination positivity titers and compared by means of CRP, MPV and platelet values. We also investigated the relationship among logarithmic values of MPV, platelet and CRP parameters for each group.
RESULTS: Although statistically meaningful difference was observed between control and patients group in terms of MPV and platelet value, there were no statistically significant differences observed among patients groups. The physiological negative correlation between MPV and platelet count was not encountered in group 2 and 3. Logarithmic values of CRP were not correlated with logarithmic values of MPV and platelet counts.
CONCLUSION: The MPV could be a new parameter to evaluate hematologic abnormalities in patients with brucellosis. The SAT titer was not a useful measure for evaluation of the severity of brucellosis.

Entities:  

Keywords:  Brucella; CRP; agglutination; mean platelet volume; platelet count

Mesh:

Substances:

Year:  2014        PMID: 25834485      PMCID: PMC4370056          DOI: 10.4314/ahs.v14i4.4

Source DB:  PubMed          Journal:  Afr Health Sci        ISSN: 1680-6905            Impact factor:   0.927


  25 in total

Review 1.  C-reactive protein and the acute phase response.

Authors:  S P Ballou; I Kushner
Journal:  Adv Intern Med       Date:  1992

2.  Platelet and mean platelet volume kinetics in adult patients with sepsis.

Authors:  Hande Aydemir; Nihal Piskin; Deniz Akduman; Furuzan Kokturk; Elif Aktas
Journal:  Platelets       Date:  2012-06-25       Impact factor: 3.862

3.  A panel of eight tests in the serodiagnosis and immunological evaluation of acute brucellosis.

Authors:  W A Dabdoob; Z A Abdulla
Journal:  East Mediterr Health J       Date:  2000 Mar-May       Impact factor: 1.628

4.  C-reactive protein as a prognostic indicator in acute brucellosis.

Authors:  J M Navarro; J Mendoza; J Leiva; R Rodríguez-Contreras; M de la Rosa
Journal:  Diagn Microbiol Infect Dis       Date:  1990 May-Jun       Impact factor: 2.803

5.  Comparison of the Brucella Standard Agglutination Test with the ELISA IgG and IgM in patients with Brucella bacteremia.

Authors:  Z A Memish; M Almuneef; M W Mah; L A Qassem; A O Osoba
Journal:  Diagn Microbiol Infect Dis       Date:  2002-10       Impact factor: 2.803

6.  Evaluation of serum C-reactive protein in the diagnosis of arthritic and non-arthritic brucellosis.

Authors:  A S al-Kassab; M A Nur; J M Malik
Journal:  J Trop Med Hyg       Date:  1991-04

7.  Brucella bacteraemia: clinical and laboratory observations in 160 patients.

Authors:  Z Memish; M W Mah; S Al Mahmoud; M Al Shaalan; M Y Khan
Journal:  J Infect       Date:  2000-01       Impact factor: 6.072

Review 8.  Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis.

Authors:  Liliana Simon; France Gauvin; Devendra K Amre; Patrick Saint-Louis; Jacques Lacroix
Journal:  Clin Infect Dis       Date:  2004-07-02       Impact factor: 9.079

9.  Brucella species release a specific, protease-sensitive, inhibitor of TNF-alpha expression, active on human macrophage-like cells.

Authors:  E Caron; A Gross; J P Liautard; J Dornand
Journal:  J Immunol       Date:  1996-04-15       Impact factor: 5.422

10.  Mean platelet volume as an indicator of platelet activation: methodological issues.

Authors:  Yongsoon Park; Norberta Schoene; William Harris
Journal:  Platelets       Date:  2002 Aug-Sep       Impact factor: 3.862

View more
  7 in total

1.  Editorial.

Authors:  James Tumwine
Journal:  Afr Health Sci       Date:  2014-12       Impact factor: 0.927

2.  Relation between mean platelet volume and C-reactive protein.

Authors:  Somedeb Ball; Jeff A Dennis; Genanew Bedanie; Kenneth Nugent
Journal:  Proc (Bayl Univ Med Cent)       Date:  2020-01-10

3.  Diagnostic role of inflammatory markers in pediatric Brucella arthritis.

Authors:  Fesih Aktar; Recep Tekin; Mehmet Selçuk Bektaş; Ali Güneş; Muhammet Köşker; Sabahattin Ertuğrul; Kamil Yılmaz; Kamuran Karaman; Hasan Balık; İlyas Yolbaş
Journal:  Ital J Pediatr       Date:  2016-01-11       Impact factor: 2.638

Review 4.  Rickettsia burneti and Brucella melitensis co-infection: a case report and literature review.

Authors:  Jiangqin Song; Junyang Zhou; Xiaorong Hu; Xiaolong Li; Youping Chen; Xiangyuan Yan; Weifang Zhu; Yan Ding
Journal:  BMC Microbiol       Date:  2021-10-05       Impact factor: 3.605

5.  Diagnostic role of mean platelet volume and neutrophil to lymphocyte ratio in childhood brucellosis.

Authors:  Şefika Elmas Bozdemir; Yasemin Ay Altıntop; Salih Uytun; Humeyra Aslaner; Yasemin Altuner Torun
Journal:  Korean J Intern Med       Date:  2016-12-14       Impact factor: 2.884

6.  Comparison of inflammatory markers between brucella and non-brucella epididymo-orchitis.

Authors:  Ali Cift; Mehmet Ozgur Yucel
Journal:  Int Braz J Urol       Date:  2018 Jul-Aug       Impact factor: 1.541

7.  Usefulness of Blood Parameters for Preliminary Diagnosis of Brucellosis.

Authors:  Alisha Akya; Arezoo Bozorgomid; Kayghobad Ghadiri; Mahnaz Ahmadi; Azam Elahi; Hadi Mozafari; Afshin Almasi; Parvin Namadi; Roya Chegenelorestani
Journal:  J Blood Med       Date:  2020-03-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.